Partner with us to meet your needs for best-in-class risk-mitigating solutions with technical and regulatory expertise. Learn more about our biosafety testing, analytical development, and biomanufacturing services and how they span the product cycle from early preclinical development to licensed production! Learn more.
Biopharma sustainability will require the industry to not shy away from public opinion but meet it head on. Winning short-term battles, however impressively as with creation of the COVID vaccines, may not be enough to secure total victory.
I thought I’d peel a layer off the onion to reveal a trend that’s gaining momentum and having a positive impact during a somewhat negative biopharma news cycle: computational biology.
Designing and conducting trials during the COVID-19 global pandemic forced clinical teams to be creative, to explore the use of technology, and to design a trial that meets the participants where they are — without compromising outcomes.
This guide explores the regulatory strategy considerations sponsors should bear in mind when working with global regulatory agencies, with a focus on the development of drug and biologic products.
Allogeneic cell therapies offer great clinical promise, but they also pose unique challenges. Here, we highlight tips to make the translational journey easier.
Think you have a good idea for an article that Life Science Leader readers would find valuable? Read these guidelines first before submitting your idea or your article to our editorial director.
Connect With Life Science Leader:
This website uses cookies to ensure you get the best experience on our website. Learn more
